Huntington National Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.4K | Buy |
129
+25
| +24% | +$4.37K | ﹤0.01% | 1581 |
|
|
2025
Q4 | $17.7K | Sell |
104
-6
| -5% | -$920 | ﹤0.01% | 1623 |
|
|
2025
Q3 | $14.5K | Sell |
110
-1
| -0.9% | -$120 | ﹤0.01% | 1710 |
|
|
2025
Q2 | $11.8K | Buy |
111
+10
| +10% | +$1.09K | ﹤0.01% | 1743 |
|
|
2025
Q1 | $12.5K | Buy |
101
+51
| +102% | +$6.65K | ﹤0.01% | 1675 |
|
|
2024
Q4 | $6.16K | Sell |
50
-7
| -12% | -$825 | ﹤0.01% | 1930 |
|
|
2024
Q3 | $6.35K | Sell |
57
-177
| -76% | -$19.4K | ﹤0.01% | 1920 |
|
|
2024
Q2 | $25K | Sell |
234
-221
| -49% | -$24.3K | ﹤0.01% | 1391 |
|
|
2024
Q1 | $54.8K | Sell |
455
-28
| -6% | -$3.43K | ﹤0.01% | 1095 |
|
|
2023
Q4 | $59.4K | Buy |
483
+95
| +24% | +$11.9K | ﹤0.01% | 1021 |
|
|
2023
Q3 | $50.2K | Buy |
388
+5
| +1% | +$666 | ﹤0.01% | 1038 |
|
|
2023
Q2 | $47.5K | Sell |
383
-39
| -9% | -$5.25K | ﹤0.01% | 1073 |
|
|
2023
Q1 | $61.8K | Buy |
422
+98
| +30% | +$14.5K | ﹤0.01% | 940 |
|
|
2022
Q4 | $51.6K | Buy |
324
+89
| +38% | +$13K | ﹤0.01% | 992 |
|
|
2022
Q3 | $31K | Buy |
+235
| New | +$35.7K | ﹤0.01% | 1129 |
|
|
2022
Q1 | – | Sell |
-37
| Closed | -$5K | – | 2188 |
|
|
2021
Q4 | $5K | Hold |
37
| – | – | ﹤0.01% | 1728 |
|
|
2021
Q3 | $5K | Sell |
37
-54
| -59% | -$8.16K | ﹤0.01% | 1568 |
|
|
2021
Q2 | $16K | Buy |
91
+37
| +69% | +$6.41K | ﹤0.01% | 1317 |
|
|
2021
Q1 | $9K | Hold |
54
| – | – | ﹤0.01% | 1358 |
|
|
2020
Q4 | $9K | Buy |
+54
| New | +$8.04K | ﹤0.01% | 1315 |
|
|
2020
Q3 | – | Sell |
-85
| Closed | -$9K | – | 1621 |
|
|
2020
Q2 | $9K | Buy |
85
+48
| +130% | +$5.31K | ﹤0.01% | 1227 |
|
|
2020
Q1 | $4K | Sell |
37
-127
| -77% | -$16.4K | ﹤0.01% | 1365 |
|
|
2019
Q4 | $24K | Buy |
+164
| New | +$22.3K | ﹤0.01% | 1196 |
|
|
2019
Q1 | – | Sell |
-27
| Closed | -$3K | – | 1663 |
|
|
2018
Q4 | $3K | Hold |
27
| – | – | ﹤0.01% | 1518 |
|
|
2018
Q3 | $5K | Hold |
27
| – | – | ﹤0.01% | 1504 |
|
|
2018
Q2 | $5K | Buy |
+27
| New | +$4.41K | ﹤0.01% | 1443 |
|
|
2016
Q4 | – | Sell |
-946
| Closed | -$115K | – | 1470 |
|
|
2016
Q3 | $115K | Sell |
946
-182
| -16% | -$24.5K | ﹤0.01% | 739 |
|
|
2016
Q2 | $159K | Sell |
1,128
-422
| -27% | -$62.2K | ﹤0.01% | 606 |
|
|
2016
Q1 | $268K | Buy |
1,550
+324
| +26% | +$40.3K | 0.01% | 559 |
|
|
2015
Q4 | $172K | Sell |
1,226
-312
| -20% | -$43.2K | ﹤0.01% | 651 |
|
|
2015
Q3 | $204K | Sell |
1,538
-2
| -0.1% | -$344 | 0.01% | 614 |
|
|
2015
Q2 | $271K | Sell |
1,540
-10
| -0.6% | -$1.8K | 0.01% | 574 |
|
|
2015
Q1 | $268K | Buy |
1,550
+38
| +3% | +$6.52K | 0.01% | 561 |
|
|
2014
Q4 | $248K | Sell |
1,512
-13,094
| -90% | -$2.17M | 0.01% | 604 |
|
|
2014
Q3 | $2.35M | Buy |
14,606
+1,106
| +8% | +$170K | 0.05% | 333 |
|
|
2014
Q2 | $1.99M | Buy |
+13,500
| New | +$1.87M | 0.04% | 424 |
|
|
2014
Q1 | – | Sell |
-60
| Closed | -$8K | – | 1350 |
|
|
2013
Q4 | $8K | Sell |
60
-27
| -31% | -$2.79K | ﹤0.01% | 1480 |
|
|
2013
Q3 | $8K | Buy |
87
+20
| +30% | +$1.61K | ﹤0.01% | 1492 |
|
|
2013
Q2 | $5K | Buy |
+67
| New | +$4.09K | ﹤0.01% | 1539 |
|
Other funds holding JAZZ
VPM
VCM
EC
Huntington National Bank's JAZZ Position: Q1 2026 in Review
Huntington National Bank increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q1 2026, buying an estimated $4.37K and bringing the position to 129 shares worth $24.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1581.
Huntington National Bank first reported a position in JAZZ in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.35M in Q3 2014. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Huntington National Bank held 129 shares of Jazz Pharmaceuticals worth $24.4K as of Q1 2026.
- Huntington National Bank bought 25 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.37K.
- Jazz Pharmaceuticals made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1581 holding.
- Huntington National Bank first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 39 quarters since.
- Huntington National Bank's Jazz Pharmaceuticals position peaked at $2.35M in Q3 2014.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.